NO970172L - Kationiske amfifiler - Google Patents

Kationiske amfifiler

Info

Publication number
NO970172L
NO970172L NO970172A NO970172A NO970172L NO 970172 L NO970172 L NO 970172L NO 970172 A NO970172 A NO 970172A NO 970172 A NO970172 A NO 970172A NO 970172 L NO970172 L NO 970172L
Authority
NO
Norway
Prior art keywords
cationic amphiphiles
amphiphiles
cationic
diacylphosphatidyl
phosphatidylethanolamine
Prior art date
Application number
NO970172A
Other languages
English (en)
Norwegian (no)
Other versions
NO970172D0 (no
Inventor
Timothy D Heath
Original Assignee
Megabios Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megabios Corp filed Critical Megabios Corp
Publication of NO970172L publication Critical patent/NO970172L/no
Publication of NO970172D0 publication Critical patent/NO970172D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
NO970172A 1994-06-22 1997-01-15 Kationiske amfifiler NO970172D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/007071 WO1995035301A1 (en) 1994-06-22 1994-06-22 Cationic amphiphiles

Publications (2)

Publication Number Publication Date
NO970172L true NO970172L (no) 1997-01-15
NO970172D0 NO970172D0 (no) 1997-01-15

Family

ID=22242692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970172A NO970172D0 (no) 1994-06-22 1997-01-15 Kationiske amfifiler

Country Status (6)

Country Link
EP (1) EP0807116A4 (ja)
JP (1) JPH10506093A (ja)
AU (1) AU696881B2 (ja)
CA (1) CA2194221C (ja)
NO (1) NO970172D0 (ja)
WO (1) WO1995035301A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
JP4335310B2 (ja) * 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US6235310B1 (en) 1997-04-04 2001-05-22 Valentis, Inc. Methods of delivery using cationic lipids and helper lipids
US7780882B2 (en) 1999-02-22 2010-08-24 Georgetown University Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
US9034329B2 (en) 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
US9034330B2 (en) 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
EP1811036B8 (en) 1999-02-22 2011-09-21 Georgetown University Antibody fragment-targeted immunoliposomes for systemic gene delivery
AU2002307035A1 (en) * 2001-04-02 2002-10-15 Georgetown University A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
DE10207178A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Komponenten für die Herstellung amphoterer Liposomen
WO2004002453A1 (en) 2002-06-28 2004-01-08 Protiva Biotherapeutics Ltd. Method and apparatus for producing liposomes
AU2004257373B2 (en) 2003-07-16 2011-03-24 Arbutus Biopharma Corporation Lipid encapsulated interfering RNA
NZ592917A (en) 2003-09-15 2012-12-21 Protiva Biotherapeutics Inc Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
ATE536418T1 (de) 2004-06-07 2011-12-15 Protiva Biotherapeutics Inc Lipidverkapselte interferenz-rna
EP1781593B1 (en) 2004-06-07 2011-12-14 Protiva Biotherapeutics Inc. Cationic lipids and methods of use
JP2008504827A (ja) 2004-07-02 2008-02-21 プロチバ バイオセラピューティクス インコーポレイティッド 免疫賦活性ｓｉＲＮＡ分子およびその使用方法
EP1948674A4 (en) 2005-11-02 2009-02-04 Protiva Biotherapeutics Inc MODIFIED SIRNA MOLECULES AND APPLICATIONS THEREOF
US7915399B2 (en) 2006-06-09 2011-03-29 Protiva Biotherapeutics, Inc. Modified siRNA molecules and uses thereof
AU2009238175C1 (en) 2008-04-15 2023-11-30 Arbutus Biopharma Corporation Novel lipid formulations for nucleic acid delivery
AU2009303345B2 (en) 2008-10-09 2015-08-20 Arbutus Biopharma Corporation Improved amino lipids and methods for the delivery of nucleic acids
US9018187B2 (en) 2009-07-01 2015-04-28 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
WO2011000106A1 (en) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Improved cationic lipids and methods for the delivery of therapeutic agents
CA2767127A1 (en) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Novel lipid formulations for delivery of therapeutic agents to solid tumors
WO2012000104A1 (en) 2010-06-30 2012-01-05 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
GB2578557B (en) 2013-07-16 2020-09-02 Univ Leland Stanford Junior Enhancement of osteogenic potential of bone grafts
JP2023553343A (ja) 2020-11-25 2023-12-21 アカゲラ・メディスンズ，インコーポレイテッド 核酸を送達するための脂質ナノ粒子および関連する使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5334761A (en) * 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
US5651981A (en) * 1994-03-29 1997-07-29 Northwestern University Cationic phospholipids for transfection

Also Published As

Publication number Publication date
EP0807116A4 (en) 1998-01-07
JPH10506093A (ja) 1998-06-16
AU696881B2 (en) 1998-09-24
WO1995035301A1 (en) 1995-12-28
CA2194221C (en) 2001-01-02
EP0807116A1 (en) 1997-11-19
CA2194221A1 (en) 1995-12-28
AU7471194A (en) 1996-01-15
NO970172D0 (no) 1997-01-15

Similar Documents

Publication Publication Date Title
NO970172L (no) Kationiske amfifiler
DE69504184T2 (de) Neue kationische phospholipide zur transfektion
DK0656883T3 (da) Kationiske lipider
FI924311A (fi) Nya 2-substituerade indan-2-merkaptoacetylamidderivat anvaendbara som inhibitorer av enkefalinas och ace
NO20085413L (no) Anvendelse av estere av L-karnitin eller alkanoyl L-karnitiner som kationiske lipider for intracellulær avlevering av farmakologisk aktive forbindelser
NO914092D0 (no) Fremgangsmaate for fremstilling av mercaptoacetylamidderivater
NO955256D0 (no) Fenylheterosykluser som syklooksygenase-2-inhibitorer
AU3955089A (en) Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent
IL174301A (en) Use of the apo a – im complex: popc for the preparation of a drug for the treatment of coronary atherosclerosis and serious coronary syndromes
FI971104A (fi) Menetelmä COX-inhibiittoreina käyttökelpoisten fenyyliheterosyklien valmistamiseksi
PT97905A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cistina
ID21545A (id) Turunan biphenil yang tersubstitusi dengan radikal aromatik atau heteroaromatik, serta komposisi farmasi dan kosmetik yang mengandungnya
ATE527983T1 (de) Kosmetische und dermatologische lichtschutzformulierungen mit einem gehalt an partikulären uv-filtersubstanzen und alkylnaphthalaten
DK0789590T3 (da) Chitosaninduceret immunforstærkning
ES2108698T3 (es) Liposomas exentos de sustancias activas, para el tratamiento de aterosclerosis.
NO912629L (no) Fremgangsmaate for fremstilling av nye bis(4-(2,6-dialkyl)fenol)silanderivater som antiarteriosklerotiske midler
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
CO5180595A1 (es) Sistemas policiclicos de tiazol, procedimiento para su preparacion y medicamento que contiene a estos compuestos
DE69606364T2 (de) Prostaglandinderivate
PT96563A (pt) Metodo para a preparacao de uma formulacao farmaceutica contendo um derivado de guanina
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
PT1075461E (pt) Esteres perfluorinados de l-carnitina de alcanoilo para a preparacao de lipidoscationicos para a libertacao intracelular de compostos farmacologicamente activos
NO992552D0 (no) Preparat inneholdende diarylalkanderivat som aktiv bestanddel for behandling eller forhindring av pankreatitt
ITMI930693A0 (it) Metodo per la rimozione di prodotti idrocarburi da superfici acquose
GR1001409B (el) Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια.